AAAAAA

   
Results: 1-11 |
Results: 11
Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults (vol 28, pg 79, 2001)
Authors: Reith, DM Hooper, WD Parke, J Charles, B
Citation: Dm. Reith et al., Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults (vol 28, pg 79, 2001), J PHARMA PH, 28(4), 2001, pp. 413-413
Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults
Authors: Reith, DM Hooper, WD Parke, J Charles, B
Citation: Dm. Reith et al., Population pharmacokinetic modeling of steady state carbamazepine clearance in children, adolescents, and adults, J PHARMA PH, 28(1), 2001, pp. 79-92
Evaluation of a pharmacokinetic interaction between remacemide hydrochloride and phenobarbitone in healthy males
Authors: Hooper, WD Eadie, MJ Blakey, GE Lockton, JA Manu'Ebo, M
Citation: Wd. Hooper et al., Evaluation of a pharmacokinetic interaction between remacemide hydrochloride and phenobarbitone in healthy males, BR J CL PH, 51(3), 2001, pp. 249-255
Disposition of naproxen, naproxen acyl glucuronide and its rearrangement isomers in the isolated perfused rat liver
Authors: Lo, A Addison, RS Hooper, WD Dickinson, RG
Citation: A. Lo et al., Disposition of naproxen, naproxen acyl glucuronide and its rearrangement isomers in the isolated perfused rat liver, XENOBIOTICA, 31(6), 2001, pp. 309-319
Valproate metabolism during valproate-associated hepatotoxicity in a surviving adult patient
Authors: McLaughlin, DB Eadie, MJ Parker-Scott, SL Addison, RS Henderson, RD Hooper, WD Dickinson, RG
Citation: Db. Mclaughlin et al., Valproate metabolism during valproate-associated hepatotoxicity in a surviving adult patient, EPILEPSY R, 41(3), 2000, pp. 259-268
Apparent autoinduction of valproate beta-oxidation in humans
Authors: McLaughlin, DB Andrews, JA Hooper, WD Cannell, GR Eadie, MJ Dickinson, RG
Citation: Db. Mclaughlin et al., Apparent autoinduction of valproate beta-oxidation in humans, BR J CL PH, 49(5), 2000, pp. 409-415
Effect of naproxen co-administration on valproate disposition
Authors: Addison, RS Parker-Scott, SL Hooper, WD Eadie, MJ Dickinson, RG
Citation: Rs. Addison et al., Effect of naproxen co-administration on valproate disposition, BIOPHARM DR, 21(6), 2000, pp. 235-242
Phenytoin metabolism by human cytochrome P450: Involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation
Authors: Cuttle, L Munns, AJ Hogg, NA Scott, JR Hooper, WD Dickinson, RG Gillam, EMJ
Citation: L. Cuttle et al., Phenytoin metabolism by human cytochrome P450: Involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation, DRUG META D, 28(8), 2000, pp. 945-950
Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers
Authors: Addison, RS Parker-Scott, SL Eadie, MJ Hooper, WD Dickinson, RG
Citation: Rs. Addison et al., Steady-state dispositions of valproate and diflunisal alone and coadministered to healthy volunteers, EUR J CL PH, 56(9-10), 2000, pp. 715-721
Measurement of anticonvulsants and their metabolites in biological fluids
Authors: Hooper, WD Johnson, LP
Citation: Wd. Hooper et Lp. Johnson, Measurement of anticonvulsants and their metabolites in biological fluids, HANDB EXP P, 138, 1999, pp. 173-187
Metabolic drug interactions
Authors: Hooper, WD
Citation: Wd. Hooper, Metabolic drug interactions, HANDBOOK OF DRUG METABOLISM, 1999, pp. 229-238
Risultati: 1-11 |